Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01355
|
|||||
| Drug Name |
Formoterol
|
|||||
| Synonyms |
Foradile; Formoterol tartrate; Oxeze Turbuhaler Foradil; MOLI000351; Atimos (TN); Atock (TN); Foradil (TN); Foradile (TN); Formoterol (INN); Modulite (TN); Oxeze (TN); Oxis (TN); Perforomist (TN); Formoterol, ((R*,R*)-(+-)-)-isomer; N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide; N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide; N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide; (+-)-2'-Hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide; 3-formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Asthma [ICD11: CA23] | Approved | [1] | |||
| Therapeutic Class |
Sympathomimetics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H24N2O4
|
|||||
| Canonical SMILES |
CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
|
|||||
| InChI |
InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1
|
|||||
| InChIKey |
BPZSYCZIITTYBL-YJYMSZOUSA-N
|
|||||
| CAS Number |
CAS 67346-49-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 344.4 | Topological Polar Surface Area | 90.8 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
1.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10007
, 5643479
, 8152174
, 14875897
, 29222544
, 46507099
, 50125837
, 50940891
, 53790377
, 57321784
, 85209082
, 92712339
, 96024684
, 103837996
, 104303431
, 117625425
, 125564207
, 126625648
, 126656778
, 126670908
, 127551521
, 134337561
, 135610485
, 136352502
, 137070085
, 142452394
, 144224272
, 152100598
, 160964320
, 162178864
, 163329494
, 176251370
, 178100459
, 179148573
, 196111556
, 198992021
, 206246320
, 221672992
, 223400949
, 223680169
, 223781951
, 226683973
, 240785438
|
|||||
| ChEBI ID |
CHEBI:408174
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Formoterol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.